PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma. Gelmi MC, Gezgin G, van der Velden PA, Luyten GPM, et al. Invest Ophthalmol Vis Sci 2023;64:36.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gelmi MC, Gezgin G, van der Velden PA, Luyten GPM, et al. PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma. Invest Ophthalmol Vis Sci 2023;64:36.
PMID: 38149971